Zensar Technologies acquires BridgeView Life Sciences LLC

18 Jul 2024 Evaluate

Zensar Technologies has acquired BridgeView Life Sciences LLC. The US?based leader in information technology and operations provides a comprehensive range of advisory, transformation, and managed services exclusively for life sciences customers endeavoring to launch products or new indications, assess and optimize their operations, or engage in merger or acquisition transactions. This strategic move strengthens Zensar's Healthcare and Life Sciences (HLS) vertical and expands its pharma commercial and product launch expertise.

The acquisition positions Zensar to offer a more comprehensive suite of solutions to pharmaceutical, biotechnology, and medical device companies. BridgeView's ‘Preferred Services Partner’ and ‘Services Partner’ status with Veeva Systems' Commercial Cloud and Development Cloud, respectively, solidify Zensar's position as a trusted technology partner. Additionally, BridgeView's partnerships with Reltio, Datavant, Snowflake, Salesforce, and IQVIA bolster its capabilities. The acquisition positions Zensar as a pivotal force in driving innovation and facilitating the digital transformation of life sciences companies, effectively addressing the industry's key challenges.  

Zensar Technologies, formerly known as ICIL was acquired by the RPG group in 1989. It is a globally focused software and services company spread across eighteen countries across the world. 


Zensar Technologies Share Price

766.70 -9.65 (-1.24%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
TCS 4168.05
Infosys 1922.05
HCL Tech. 1911.20
Wipro 305.15
Tech Mahindra 1685.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.